Citations (539)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (38)
Iacopo Panarese, Gabriella Aquino, Andrea Ronchi, Francesco Longo, Marco Montella, Immacolata Cozzolino, Giuseppe Roccuzzo, Giuseppe Colella, Michele Caraglia & Renato Franco. (2019) Oral and Oropharyngeal squamous cell carcinoma: prognostic and predictive parameters in the etiopathogenetic route. Expert Review of Anticancer Therapy 19:2, pages 105-119.
Read now
Read now
Benjamin L. Bryson, Damian J. Junk, Rocky Cipriano & Mark W. Jackson. (2017) STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence. Cell Cycle 16:4, pages 319-334.
Read now
Read now
Serge Haan, Christelle Bahlawane, Jiali Wang, Petr V Nazarov, Arnaud Muller, René Eulenfeld, Claude Haan, Catherine Rolvering, Laurent Vallar, Venkata P Satagopam, Thomas Sauter & Monique Yvonne Wiesinger. (2015) The oncogenic FIP1L1-PDGFRα fusion protein displays skewed signaling properties compared to its wild-type PDGFRα counterpart. JAK-STAT 4:1.
Read now
Read now
Young-Il Kim, Kyungho Park, Jong Youl Kim, Ho Seong Seo, Kyong-Oh Shin, Yong-Moon Lee, Walter M. Holleran, Peter M. Elias & Yoshikazu Uchida. (2014) An Endoplasmic Reticulum Stress-Initiated Sphingolipid Metabolite, Ceramide-1-Phosphate, Regulates Epithelial Innate Immunity by Stimulating β-Defensin Production. Molecular and Cellular Biology 34:24, pages 4368-4378.
Read now
Read now
Jihye Ryu, Minkyung Kang, Mi-Sook Lee, Hye-Jin Kim, Seo Hee Nam, Haeng Eun Song, Doohyung Lee & Jung Weon Lee. (2014) Cross Talk between the TM4SF5/Focal Adhesion Kinase and the Interleukin-6/STAT3 Pathways Promotes Immune Escape of Human Liver Cancer Cells. Molecular and Cellular Biology 34:16, pages 2946-2960.
Read now
Read now
Yu-Jung Chang, Kuan-Wei Chen, Ching-Jen Chen, Ming-Hsing Lin, Yuh-Ju Sun, Jia-Lin Lee, Ing-Ming Chiu & Linyi Chen. (2014) SH2B1β Interacts with STAT3 and Enhances Fibroblast Growth Factor 1-Induced Gene Expression during Neuronal Differentiation. Molecular and Cellular Biology 34:6, pages 1003-1019.
Read now
Read now
Noah D Peyser & Jennifer R Grandis. (2013) Critical analysis of the potential for targeting STAT3 in human malignancy. OncoTargets and Therapy 6, pages 999-1010.
Read now
Read now
Mulu Geletu, Stephanie Guy, Rozanne Arulanandam, Hélène Feracci & Leda Raptis. (2013) Engaged for survival. JAK-STAT 2:4.
Read now
Read now
Jérome Bourgeais, Valérie Gouilleux-Gruart & Fabrice Gouilleux. (2013) Oxidative metabolism in cancer. JAK-STAT 2:4.
Read now
Read now
Lauren T Bourke, Richard A Knight, David S Latchman, Anastasis Stephanou & James McCormick. (2013) Signal transducer and activator of transcription-1 localizes to the mitochondria and modulates mitophagy. JAK-STAT 2:4.
Read now
Read now
Hélène Sellier, Amélie Rébillard, Catherine Guette, Benjamin Barré & Olivier Coqueret. (2013) How should we define STAT3 as an oncogene and as a potential target for therapy?. JAK-STAT 2:3.
Read now
Read now
Adetola L Shodeinde & Beverly E Barton. (2012) Potential use of STAT3 inhibitors in targeted prostate cancer therapy: future prospects. OncoTargets and Therapy 5, pages 119-125.
Read now
Read now
Hiu Kiu & Sandra E. Nicholson. (2012) Biology and significance of the JAK/STAT signalling pathways. Growth Factors 30:2, pages 88-106.
Read now
Read now
Jonathan Ross Hart, Lujian Liao, Lynn Ueno, John R. Yates III & Peter K. Vogt. (2011) Protein expression profiles of C3H 10T1/2 murine fibroblasts and of isogenic cells transformed by the H1047R mutant of phosphoinositide 3-kinase (PI3K). Cell Cycle 10:6, pages 971-976.
Read now
Read now
Devalingam Mahalingam, Kevin R Kelly, Ronan T Swords, Jennifer Carew, Steffan T Nawrocki & Francis J Giles. (2009) Emerging drugs in the treatment of pancreatic cancer. Expert Opinion on Emerging Drugs 14:2, pages 311-328.
Read now
Read now
Katherine A Peebles, Jay M Lee, Jenny T Mao, Saswati Hazra, Karen L Reckamp, Kostyantyn Krysan, Mariam Dohadwala, Eileen L Heinrich, Tonya C Walser, Xiaoyan Cui, Felicita E Baratelli, Edward Garon, Sherven Sharma & Steven M Dubinett. (2007) Inflammation and lung carcinogenesis: applying findings in prevention and treatment. Expert Review of Anticancer Therapy 7:10, pages 1405-1421.
Read now
Read now
Rebecca J Leeman, Vivian Wai Yan Lui & Jennifer Rubin Grandis. (2006) STAT3 as a therapeutic target in head and neck cancer. Expert Opinion on Biological Therapy 6:3, pages 231-241.
Read now
Read now
Weizhou Zhang, Cong S. Zong, Ulrich Hermanto, Pablo Lopez-Bergami, Ze'ev Ronai & Lu-Hai Wang. (2006) RACK1 Recruits STAT3 Specifically to Insulin and Insulin-Like Growth Factor 1 Receptors for Activation, Which Is Important for Regulating Anchorage-Independent Growth. Molecular and Cellular Biology 26:2, pages 413-424.
Read now
Read now
Guilian Niu, Kenneth L. Wright, Yihong Ma, Gabriela M. Wright, Mei Huang, Rosalyn Irby, Jon Briggs, James Karras, W. Douglas Cress, Drew Pardoll, Richard Jove, Jiangdong Chen & Hua Yu. (2005) Role of Stat3 in Regulating p53 Expression and Function. Molecular and Cellular Biology 25:17, pages 7432-7440.
Read now
Read now
Suman Kambhampati, Amit Verma, Yongzhong Li, Simrit Parmar, Antonella Sassano & Leonidas Platanias. (2004) Signalling Pathways Activated by All-trans-Retinoic Acid in Acute Promyelocytic Leukemia Cells. Leukemia & Lymphoma 45:11, pages 2175-2185.
Read now
Read now
James Turkson. (2004) STAT proteins as novel targets for cancer drug discovery. Expert Opinion on Therapeutic Targets 8:5, pages 409-422.
Read now
Read now
M. A. Westhoff, B. Serrels, V. J. Fincham, M. C. Frame & N. O. Carragher. (2004) Src-Mediated Phosphorylation of Focal Adhesion Kinase Couples Actin and Adhesion Dynamics to Survival Signaling. Molecular and Cellular Biology 24:18, pages 8113-8133.
Read now
Read now
Vidya Mamidipudi, Jian Zhang, Kelly C. Lee & Christine A. Cartwright. (2004) RACK1 Regulates G1/S Progression by Suppressing Src Kinase Activity. Molecular and Cellular Biology 24:15, pages 6788-6798.
Read now
Read now
Hideaki Ishikawa, Naohiro Tsuyama, Saeid Abroun, Shangqin Liu, Fu-Jun Li, Ken-Ichiro Otsuyama, Xu Zheng & Michio M. Kawano. (2003) Interleukin-6, CD45 and the Src-Kinases in Myeloma Cell Proliferation. Leukemia & Lymphoma 44:9, pages 1477-1481.
Read now
Read now
Tomi Sawyer, Brendan Boyce, David Dalgarno & John Iuliucci. (2001) Src inhibitors: genomics to therapeutics. Expert Opinion on Investigational Drugs 10:7, pages 1327-1344.
Read now
Read now
Sandra Hapke, Meinrad Gawaz, Kerstin Dehne, Jenny Köhler, John F. Marshall, Henner Graeff, Manfred Schmitt, Ute Reuning & Ernst Lengyel. (2001) β3A-Integrin Downregulates the Urokinase-Type Plasminogen Activator Receptor (u-PAR) through aPEA3/ets Transcriptional Silencing Element in the u-PAR Promoter. Molecular and Cellular Biology 21:6, pages 2118-2132.
Read now
Read now
Brian L. Webb, Elsa Jimenez & G. Steven Martin. (2000) v-Src Generates a p53-Independent Apoptotic Signal. Molecular and Cellular Biology 20:24, pages 9271-9280.
Read now
Read now
Tong Zhang, Wei Hua Kee, Kah Tong Seow, Winnie Fung & Xinmin Cao. (2000) The Coiled-Coil Domain of Stat3 Is Essential for Its SH2 Domain-Mediated Receptor Binding and Subsequent Activation Induced by Epidermal Growth Factor and Interleukin-6. Molecular and Cellular Biology 20:19, pages 7132-7139.
Read now
Read now
Takuya Ohtani, Katsuhiko Ishihara, Toru Atsumi, Yuichi Yoshida, Keigo Nishida, Masahiro Narimatsu, Takahiro Shirogane, Masahiko Hibi & Toshio Hirano. (2000) gp130-mediated signalling as a therapeutic target. Emerging Therapeutic Targets 4:4, pages 459-479.
Read now
Read now
Yuh-Tyng Tsai, Yi-Hsien Su, Shih-Shuan Fang, Tzye-Nan Huang, Yun Qiu, Yuh-Shan Jou, Hsiu-ming Shih, Hsing-Jien Kung & Ruey-Hwa Chen. (2000) Etk, a Btk Family Tyrosine Kinase, Mediates Cellular Transformation by Linking Src to STAT3 Activation. Molecular and Cellular Biology 20:6, pages 2043-2054.
Read now
Read now
Gregg L. Semenza. (2000) Hypoxia, Clonal Selection, and the Role of HIF-1 in Tumor Progression. Critical Reviews in Biochemistry and Molecular Biology 35:2, pages 71-103.
Read now
Read now
James Turkson, Tammy Bowman, Jalila Adnane, Yi Zhang, Julie Y. Djeu, Madhavi Sekharam, David A. Frank, Lawrence B. Holzman, Jie Wu, Said Sebti & Richard Jove. (1999) Requirement for Ras/Rac1-Mediated p38 and c-Jun N-Terminal Kinase Signaling in Stat3 Transcriptional Activity Induced by the Src Oncoprotein. Molecular and Cellular Biology 19:11, pages 7519-7528.
Read now
Read now
Yaron Hakak & G. Steven Martin. (1999) Cas Mediates Transcriptional Activation of the Serum Response Element by Src. Molecular and Cellular Biology 19:10, pages 6953-6962.
Read now
Read now
Karl-Josef Kallen, Peter Robert Galle & Stefan Rose-John. (1999) New developments in IL-6 dependent biology and therapy: where do we stand and what are the options?. Expert Opinion on Investigational Drugs 8:9, pages 1327-1349.
Read now
Read now
Lawrence H. Milocco, Jennifer A. Haslam, Jonathan Rosen & H. Martin Seidel. (1999) Design of Conditionally Active STATs: Insights into STAT Activation and Gene Regulatory Function. Molecular and Cellular Biology 19:4, pages 2913-2920.
Read now
Read now
Daniel Besser, Jacqueline F. Bromberg, James E. Darnell$suffix/text()$suffix/text() & Hidesaburo Hanafusa. (1999) A Single Amino Acid Substitution in the v-Eyk Intracellular Domain Results in Activation of Stat3 and Enhances Cellular Transformation. Molecular and Cellular Biology 19:2, pages 1401-1409.
Read now
Read now
Toshiyuki Fukada, Yuichi Yoshida, Keigo Nishida, Takuya Ohtani, Takahiro Shirogane, Masahiko Hibi & Toshio Hirano. (1999) Signaling Through Gp130: Toward a General Scenario of Cytokine Action. Growth Factors 17:2, pages 81-91.
Read now
Read now
Sumiko Watanabe. (1998) Signal transduction of the cytokine receptor. Korean Journal of Biological Sciences 2:2, pages 153-164.
Read now
Read now
Articles from other publishers (501)
Ashleigh R. Poh & Matthias Ernst. (2023) Functional roles of SRC signaling in pancreatic cancer: Recent insights provide novel therapeutic opportunities. Oncogene 42:22, pages 1786-1801.
Crossref
Crossref
Yu-Hsuan Chen, Jinn-Yuan Hsu, Ching-Tung Chu, Yao-Wen Chang, Jia-Rong Fan, Muh-Hwa Yang & Hong-Chen Chen. (2023) Loss of cell–cell adhesion triggers cell migration through Rac1-dependent ROS generation. Life Science Alliance 6:2, pages e202201529.
Crossref
Crossref
Joohyeong Lee, Eunmi Kim, Min-Kyung Kang, Jihye Ryu, Ji Eon Kim, Eun-Ae Shin, Yangie Pinanga, Kyung-hee Pyo, Haesong Lee, Eun Hae Lee, Heejin Cho, Jayeon Cheon, Wonsik Kim, Eek-Hoon Jho, Semi Kim & Jung Weon Lee. (2022)
Systemic TM4SF5 overexpression in
Apc
Min/+
mice promotes hepatic portal hypertension associated with fibrosis
. BMB Reports 55:12, pages 609-614.
Crossref
Crossref
Yinsong Zhu, Peibin Yue, Cody F. Dickinson, Justin K. Yang, Kyrstin Datanagan, Ning Zhai, Yi Zhang, Gabriella Miklossy, Francisco Lopez-Tapia, Marcus A. Tius & James Turkson. (2022) Natural product preferentially targets redox and metabolic adaptations and aberrantly active STAT3 to inhibit breast tumor growth in vivo. Cell Death & Disease 13:12.
Crossref
Crossref
Hanad Adan, Stephanie Guy, Rozanne Arulanandam, Mulu Geletu, Juliet Daniel & Leda Raptis. (2022) Activated Src requires Cadherin-11, Rac, and gp130 for Stat3 activation and survival of mouse Balb/c3T3 fibroblasts. Cancer Gene Therapy 29:10, pages 1502-1513.
Crossref
Crossref
Hanad Adan, Juliet Daniel & Leda Raptis. (2022) Roads to Stat3 Paved with Cadherins. Cells 11:16, pages 2537.
Crossref
Crossref
Elina Khatoon, Mangala Hegde, Aviral Kumar, Uzini Devi Daimary, Gautam Sethi, Anupam Bishayee & Ajaikumar B. Kunnumakkara. (2022) The multifaceted role of STAT3 pathway and its implication as a potential therapeutic target in oral cancer. Archives of Pharmacal Research 45:8, pages 507-534.
Crossref
Crossref
Sunanda Singh, Genoveva Murillo, Justin Richner, Samara P. Singh, Erica Berleth, Vijay Kumar, Rajendra Mehta, Vijay Ramiya & Ashutosh S. Parihar. (2022) A Broad-Based Characterization of a Cell-Penetrating, Single Domain Camelid Bi-Specific Antibody Monomer That Targets STAT3 and KRAS Dependent Cancers. International Journal of Molecular Sciences 23:14, pages 7565.
Crossref
Crossref
Peibin Yue, Yinsong Zhu, Christine Brotherton-Pleiss, Wenzhen Fu, Nagendra Verma, Jasmine Chen, Kayo Nakamura, Weiliang Chen, Yue Chen, Felix Alonso-Valenteen, Simoun Mikhael, Lali Medina-Kauwe, Kathleen M. Kershaw, Maria Celeridad, Songqin Pan, Allison S. Limpert, Douglas J. Sheffler, Nicholas D.P. Cosford, Stephen L. Shiao, Marcus A. Tius, Francisco Lopez-Tapia & James Turkson. (2022) Novel potent azetidine-based compounds irreversibly inhibit Stat3 activation and induce antitumor response against human breast tumor growth in vivo. Cancer Letters 534, pages 215613.
Crossref
Crossref
Bilal Bin Hafeez, Eunmi Park, Kyung-Soo Chun, Yong-Yeon Cho & Dae Joon Kim. 2022. Regulation and Dysfunction of Apoptosis. Regulation and Dysfunction of Apoptosis.
Xiaohui Li, Binghua Liu, Jun Yang, Guangling Li, Haishen Wen, Meizhao Zhang, Jifang Li & Feng He. (2022) DNA methylation in promoter region of immune related genes STAT3 and VEGFA and biochemical parameters change in muscle of Japanese flounder under acute hypoxia. Developmental & Comparative Immunology 129, pages 104295.
Crossref
Crossref
Vidhya Tangeda, Yu Kang Lo, Ananth Ponneri Babuharisankar, Han-Yu Chou, Cheng-Liang Kuo, Yung-Hsi Kao, Alan Yueh-Luen Lee & Jang-Yang Chang. (2022) Lon upregulation contributes to cisplatin resistance by triggering NCLX-mediated mitochondrial Ca2+ release in cancer cells. Cell Death & Disease 13:3.
Crossref
Crossref
Niki Sarri, Kehuan Wang, Maria Tsioumpekou, Casimiro Castillejo-López, Johan Lennartsson, Carl-Henrik Heldin & Natalia Papadopoulos. (2022) Deubiquitinating enzymes USP4 and USP17 finetune the trafficking of PDGFRβ and affect PDGF-BB-induced STAT3 signalling. Cellular and Molecular Life Sciences 79:2.
Crossref
Crossref
Shayon Mahalanobis, Apoorva, Nikita Sharma, Ritika Luthra, Tarunya Menon & Asmita Das. 2022. Microbial Crosstalk with Immune System. Microbial Crosstalk with Immune System
75
144
.
Rajnikant Raut, Parth Gupta, Taruna Saini, Parul Mishra & Ashish Misra. 2022. Protein Kinase Inhibitors. Protein Kinase Inhibitors
479
503
.
Chakrabhavi Dhananjaya Mohan, Min Hee Yang, Shobith Rangappa, Arunachalam Chinnathambi, Sulaiman Ali Alharbi, Tahani Awad Alahmadi, Amudha Deivasigamani, Kam Man Hui, Gautam Sethi, Kanchugarakoppal S. Rangappa & Kwang Seok Ahn. (2021) 3-Formylchromone Counteracts STAT3 Signaling Pathway by Elevating SHP-2 Expression in Hepatocellular Carcinoma. Biology 11:1, pages 29.
Crossref
Crossref
Annachiara Tesoriere, Alberto Dinarello & Francesco Argenton. (2021) The Roles of Post-Translational Modifications in STAT3 Biological Activities and Functions. Biomedicines 9:8, pages 956.
Crossref
Crossref
Anna Caruso, Alexia Barbarossa, Alessia Carocci, Giovanni Salzano, Maria Stefania Sinicropi & Carmela Saturnino. (2021) Carbazole Derivatives as STAT Inhibitors: An Overview. Applied Sciences 11:13, pages 6192.
Crossref
Crossref
Wanli Zhai, Xiongjun Ye, Yinyin Wang, Yarui Feng, Ying Wang, Yuting Lin, Lidan Ding, Liu Yang, Xuning Wang, Yanshen Kuang, Xinyuan Fu, Y. Eugene Chin, Baoqing Jia, Bingtao Zhu, Fangli Ren & Zhijie Chang. (2021) CREPT/RPRD1B promotes tumorigenesis through STAT3-driven gene transcription in a p300-dependent manner. British Journal of Cancer 124:8, pages 1437-1448.
Crossref
Crossref
Huang Chen, Aiwu Bian, Lian-fang Yang, Xuan Yin, Jie Wang, Chaowen Ti, Ying Miao, Shihong Peng, Shifen Xu, Mingyao Liu, Wen-Wei Qiu & Zhengfang Yi. (2021) Targeting STAT3 by a small molecule suppresses pancreatic cancer progression. Oncogene 40:8, pages 1440-1457.
Crossref
Crossref
Yun Liu, Shijie Liao, Samuel Bennett, Haijun Tang, Dezhi Song, David Wood, Xinli Zhan & Jiake Xu. (2020) STAT3 and its targeting inhibitors in osteosarcoma. Cell Proliferation 54:2.
Crossref
Crossref
Christine Brotherton-Pleiss, Peibin Yue, Yinsong Zhu, Kayo Nakamura, Weiliang Chen, Wenzhen Fu, Casie Kubota, Jasmine Chen, Felix Alonso-Valenteen, Simoun Mikhael, Lali Medina-Kauwe, Marcus A. Tius, Francisco Lopez-Tapia & James Turkson. (2020) Discovery of Novel Azetidine Amides as Potent Small-Molecule STAT3 Inhibitors. Journal of Medicinal Chemistry 64:1, pages 695-710.
Crossref
Crossref
Manlio Tolomeo & Antonio Cascio. (2021) The Multifaced Role of STAT3 in Cancer and Its Implication for Anticancer Therapy. International Journal of Molecular Sciences 22:2, pages 603.
Crossref
Crossref
Nigus D. Ambaye & Hua E. Yu. (2020) Novel anti‐cancer candidates from a combinatorial peptide library. Chemical Biology & Drug Design 97:1, pages 87-96.
Crossref
Crossref
Mikołaj Świerczyński, Agata Szymaszkiewicz, Jakub Fichna & Marta Zielińska. (2021) New insights into molecular pathways in colorectal cancer: Adiponectin, interleukin-6 and opioid signaling. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1875:1, pages 188460.
Crossref
Crossref
Antons Martincuks, Pei-Chuan Li, Qianqian Zhao, Chunyan Zhang, Yi-Jia Li, Hua Yu & Lorna Rodriguez-Rodriguez. (2020) CD44 in Ovarian Cancer Progression and Therapy Resistance—A Critical Role for STAT3. Frontiers in Oncology 10.
Crossref
Crossref
Na Li, Xi Luo, Qilin Yu, Ping Yang, Zhishui Chen, Xinqiang Wang, Jipin Jiang, Jing Xu, Quan Gong, Decio L. Eizirik, Zhiguang Zhou, Jiajun Zhao, Fei Xiong, Shu Zhang & Cong-Yi Wang. (2020) SUMOylation of Pdia3 exacerbates proinsulin misfolding and ER stress in pancreatic beta cells. Journal of Molecular Medicine 98:12, pages 1795-1807.
Crossref
Crossref
Yinyin Wang, Sihan Liu, Guancheng Jiang, Wanli Zhai, Liu Yang, Mengdi Li, Zhijie Chang & Bingtao Zhu. (2020) NOK associates with c-Src and promotes c-Src-induced STAT3 activation and cell proliferation. Cellular Signalling 75, pages 109762.
Crossref
Crossref
Siyuan Jing, Haoyang Zou, Zidan Wu, Li Ren, Tiehua Zhang, Jie Zhang & Zhengyi Wei. (2020) Cucurbitacins: Bioactivities and synergistic effect with small-molecule drugs. Journal of Functional Foods 72, pages 104042.
Crossref
Crossref
Camille Sullivan, Nicholas E. Brown, Juozas Vasiliauskas, Peterson Pathrose, Sandra L. Starnes & Susan E. Waltz. (2020) Prostate Epithelial RON Signaling Promotes M2 Macrophage Activation to Drive Prostate Tumor Growth and Progression. Molecular Cancer Research 18:8, pages 1244-1254.
Crossref
Crossref
Lara Henze, Dorothee Schwinge & Christoph Schramm. (2020) The Effects of Androgens on T Cells: Clues to Female Predominance in Autoimmune Liver Diseases?. Frontiers in Immunology 11.
Crossref
Crossref
Kaviarasan Lakshmanan, Gowramma Byran & Manal Mohammed. (2020) A Brief Review on Dual Target of PARP1 and STAT3 for Cancer Therapy: A Novel Perception. Current Enzyme Inhibition 16:2, pages 115-134.
Crossref
Crossref
Claudia Cirotti, Claudia Contadini & Daniela Barilà. (2020) SRC Kinase in Glioblastoma: News from an Old Acquaintance. Cancers 12:6, pages 1558.
Crossref
Crossref
Estelle Brioudes, Mohamed Alibashe-Ahmed, Vanessa Lavallard, Thierry Berney & Domenico Bosco. (2020) Syndecan-4 is regulated by IL-1β in β-cells and human islets. Molecular and Cellular Endocrinology 510, pages 110815.
Crossref
Crossref
Julian Mohrherr, Iris Z. Uras, Herwig P. Moll & Emilio Casanova. (2020) STAT3: Versatile Functions in Non-Small Cell Lung Cancer. Cancers 12:5, pages 1107.
Crossref
Crossref
Margherita Peron, Alberto Dinarello, Giacomo Meneghetti, Laura Martorano, Nicola Facchinello, Andrea Vettori, Giorgio Licciardello, Natascia Tiso & Francesco Argenton. (2020) The stem-like STAT3-responsive cells of zebrafish intestine are WNT/β-catenin dependent. Development.
Crossref
Crossref
Karolina Swiatek-Machado & Bozena Kaminska. 2020. Glioma Signaling. Glioma Signaling
203
222
.
Akash Ahuja, Deok Jeong, Mi-Yeon Kim & Jae Youl Cho. (2019)
Trichosanthes tricuspidata
Lour. Methanol Extract Exhibits Anti-Inflammatory Activity by Targeting Syk, Src, and IRAK1 Kinase Activity
. Evidence-Based Complementary and Alternative Medicine 2019, pages 1-14.
Crossref
Crossref
Ethan L. Morgan & Andrew Macdonald. (2019) JAK2 Inhibition Impairs Proliferation and Sensitises Cervical Cancer Cells to Cisplatin-Induced Cell Death. Cancers 11:12, pages 1934.
Crossref
Crossref
Jhen-Jia Fan, Wen-Hsien Hsu, Kuen-Haur Lee, Ku-Chung Chen, Cheng-Wei Lin, Yu-Lin Lee, Tzu-Ping Ko, Lang-Ta Lee, Ming-Ting Lee, Mau-Sun Chang & Chia-Hsiung Cheng. (2019) Dietary Flavonoids Luteolin and Quercetin Inhibit Migration and Invasion of Squamous Carcinoma through Reduction of Src/Stat3/S100A7 Signaling. Antioxidants 8:11, pages 557.
Crossref
Crossref
Elena Butturini, Alessandra Carcereri de Prati, Diana Boriero & Sofia Mariotto. (2019) Natural Sesquiterpene Lactones Enhance Chemosensitivity of Tumor Cells through Redox Regulation of STAT3 Signaling. Oxidative Medicine and Cellular Longevity 2019, pages 1-16.
Crossref
Crossref
Chunling Li, Juan Zhang, Weiyan Wang, Hui Wang, Yue Zhang & Zhiyi Zhang. (2019) Arsenic trioxide improves Treg and Th17 balance by modulating STAT3 in treatment-naïve rheumatoid arthritis patients. International Immunopharmacology 73, pages 539-551.
Crossref
Crossref
Petra Aigner, Valentin Just & Dagmar Stoiber. (2019) STAT3 isoforms: Alternative fates in cancer?. Cytokine 118, pages 27-34.
Crossref
Crossref
Zhe JiLizhi HeAviv Regev & Kevin Struhl. (2019) Inflammatory regulatory network mediated by the joint action of NF-kB, STAT3, and AP-1 factors is involved in many human cancers. Proceedings of the National Academy of Sciences 116:19, pages 9453-9462.
Crossref
Crossref
Mulu Geletu, Zaid Taha, Patrick T. Gunning & Leda Raptis. (2019) PI3k and Stat3: Oncogenes that are Required for Gap Junctional, Intercellular Communication. Cancers 11:2, pages 167.
Crossref
Crossref
Yang Yang & Zhi Shi. 2019. Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy. Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy
53
65
.
Aws Abdul‐Wahid, Marzena Cydzik, Nicholas W. Fischer, Aaron Prodeus, John E Shively, Anne Martel, Samira Alminawi, Zeina Ghorab, Neil L. Berinstein & Jean Gariépy. (2018)
S
erum‐derived carcinoembryonic antigen (
CEA
) activates fibroblasts to induce a local re‐modeling of the extracellular matrix that favors the engraftment of
CEA
‐expressing tumor cells
. International Journal of Cancer 143:8, pages 1963-1977.
Crossref
Crossref
Alice West, Vanessa Tsui, Stanley Stylli, Hong Nguyen, Andrew Morokoff, Andrew Kaye & Rodney Luwor. (2018) The role of interleukin‑6‑STAT3 signalling in glioblastoma (Review). Oncology Letters.
Crossref
Crossref
Federica Laudisi, Fabio Cherubini, Giovanni Monteleone & Carmine Stolfi. (2018) STAT3 Interactors as Potential Therapeutic Targets for Cancer Treatment. International Journal of Molecular Sciences 19:6, pages 1787.
Crossref
Crossref
Xinyan Wang, Linyong Du, He Wei, Anying Zhang, Kun Yang & Hong Zhou. (2018) Identification of two Stat3 variants lacking a transactivation domain in grass carp: New insights into alternative splicing in the modification of teleost Stat3 signaling. Fish & Shellfish Immunology 77, pages 13-21.
Crossref
Crossref
M. Geletu, R. Mohan, R. Arulanandam, A. Berger-Becvar, I.R. Nabi, P.T. Gunning & L. Raptis. (2018) Reciprocal regulation of the Cadherin-11/Stat3 axis by caveolin-1 in mouse fibroblasts and lung carcinoma cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1865:5, pages 794-802.
Crossref
Crossref
Takayuki Maruoka, Akira Kitanaka, Yoshitsugu Kubota, Genji Yamaoka, Tomohiro Kameda, Osamu Imataki, Hiroaki Dobashi, Shuji Bandoh, Norimitsu Kadowaki & Terukazu Tanaka. (2018) Lemongrass essential oil and citral inhibit Src/Stat3 activity and suppress the proliferation/survival of small-cell lung cancer cells, alone or in combination with chemotherapeutic agents. International Journal of Oncology.
Crossref
Crossref
Mariano Caratozzolo, Flaviana Marzano, Francesca Mastropasqua, Elisabetta Sbisà & Apollonia Tullo. (2017) TRIM8: Making the Right Decision between the Oncogene and Tumour Suppressor Role. Genes 8:12, pages 354.
Crossref
Crossref
Linyong Du, Hong Zhou, Lei Qin, He Wei, Anying Zhang, Kun Yang & Xinyan Wang. (2017) Identification and functional evaluation of two STAT3 variants in grass carp: Implication for the existence of specific alternative splicing of STAT3 gene in teleost. Developmental & Comparative Immunology 76, pages 326-333.
Crossref
Crossref
Zangbéwendé Guy Ouédraogo, Julian Biau, Jean-Louis Kemeny, Laurent Morel, Pierre Verrelle & Emmanuel Chautard. (2016) Role of STAT3 in Genesis and Progression of Human Malignant Gliomas. Molecular Neurobiology 54:8, pages 5780-5797.
Crossref
Crossref
Nakho Chang, Sun Hee Ahn, Doo-Sik Kong, Hye Won Lee & Do-Hyun Nam. (2017) The role of STAT3 in glioblastoma progression through dual influences on tumor cells and the immune microenvironment. Molecular and Cellular Endocrinology 451, pages 53-65.
Crossref
Crossref
Ui Joung Youn, Tawanun Sripisut, Gabriella Miklossy, James Turkson, Surat Laphookhieo & Leng Chee Chang. (2017) Bioactive polyprenylated benzophenone derivatives from the fruits extracts of Garcinia xanthochymus. Bioorganic & Medicinal Chemistry Letters 27:16, pages 3760-3765.
Crossref
Crossref
Tzu-Ting Huang, Jung-Chen Su, Chun-Yu Liu, Chung-Wai Shiau & Kuen-Feng Chen. (2017) Alteration of SHP-1/p-STAT3 Signaling: A Potential Target for Anticancer Therapy. International Journal of Molecular Sciences 18:6, pages 1234.
Crossref
Crossref
Yong Wang, Zhi Lu, Ningning Wang, Man Zhang, Xiandong Zeng & Wei Zhao. (2017) MicroRNA-1299 is a negative regulator of STAT3 in colon cancer. Oncology Reports 37:6, pages 3227-3234.
Crossref
Crossref
Danupon Nantajit, Suwimol Jetawattana, Tawit Suriyo, David J. Grdina & Jutamaad Satayavivad. (2017) Andrographis paniculata Diterpenoids Protect against Radiation-Induced Transformation in BALB/3T3 Cells. Radiation Research 188:1, pages 66.
Crossref
Crossref
Saeideh Momtaz, Kamal Niaz, Faheem Maqbool, Mohammad Abdollahi, Luca Rastrelli & Seyed Mohammad Nabavi. (2017) STAT3 targeting by polyphenols: Novel therapeutic strategy for melanoma. BioFactors 43:3, pages 347-370.
Crossref
Crossref
Haiquan Lu, Ivan Chen, Larissa A. Shimoda, Youngrok Park, Chuanzhao Zhang, Linh Tran, Huimin Zhang & Gregg L. Semenza. (2017) Chemotherapy-Induced Ca2+ Release Stimulates Breast Cancer Stem Cell Enrichment. Cell Reports 18:8, pages 1946-1957.
Crossref
Crossref
Jacky K. Leung & Marianne D. Sadar. (2017) Non-Genomic Actions of the Androgen Receptor in Prostate Cancer. Frontiers in Endocrinology 8.
Crossref
Crossref
Jihye Ryu & Jung Weon Lee. (2017) TM4SF5-Mediated Roles in the Development of Fibrotic Phenotypes. Mediators of Inflammation 2017, pages 1-5.
Crossref
Crossref
Bart M. Maślikowski, Lizhen Wang, Ying Wu, Ben Fielding & Pierre-André Bédard. (2017)
JunD/AP-1 Antagonizes the Induction of
DAPK1
To Promote the Survival of v-Src-Transformed Cells
. Journal of Virology 91:1.
Crossref
Crossref
Dongkyoo Park, Neha Merchant & Inho Choi. 2017. Role of Transcription Factors in Gastrointestinal Malignancies. Role of Transcription Factors in Gastrointestinal Malignancies
479
493
.
Balney Rajitha & Ganji Purnachandra Nagaraju. 2017. Role of Transcription Factors in Gastrointestinal Malignancies. Role of Transcription Factors in Gastrointestinal Malignancies
427
435
.
Aleem Basha Pinjari & Abdul Razak Meerza. 2017. Role of Transcription Factors in Gastrointestinal Malignancies. Role of Transcription Factors in Gastrointestinal Malignancies
179
191
.
Jaya Srivastava & John DiGiovanni. (2016) Non-canonical Stat3 signaling in cancer. Molecular Carcinogenesis 55:12, pages 1889-1898.
Crossref
Crossref
Noah D. Peyser, Kelsey Pendleton, William E. Gooding, Vivian W. Y. Lui, Daniel E. Johnson & Jennifer R. Grandis. (2016) Genomic and Transcriptomic Alterations Associated with STAT3 Activation in Head and Neck Cancer. PLOS ONE 11:11, pages e0166185.
Crossref
Crossref
Steffanie L. Furtek, Christopher J. Matheson, Donald S. Backos & Philip Reigan. (2016) Evaluation of quantitative assays for the identification of direct signal transducer and activator of transcription 3 (STAT3) inhibitors. Oncotarget 7:47, pages 77998-78008.
Crossref
Crossref
Sarmistha Talukdar, Swadesh K. Das, Anjan K. Pradhan, Luni Emdad, Xue-Ning Shen, Jolene J. Windle, Devanand Sarkar & Paul B. Fisher. (2016) Novel function of MDA-9/Syntenin (SDCBP) as a regulator of survival and stemness in glioma stem cells. Oncotarget 7:34, pages 54102-54119.
Crossref
Crossref
Jessica L. Geiger, Jennifer R. Grandis & Julie E. Bauman. (2016) The STAT3 pathway as a therapeutic target in head and neck cancer: Barriers and innovations. Oral Oncology 56, pages 84-92.
Crossref
Crossref
HASAYA DOKDUANG, PUANGRAT YONGVANIT, NISANA NAMWAT, CHAWALIT PAIROJKUL, SAKKARN SANGKHAMANON, MIKA SAKURAI YAGETA, YOSHINORI MURAKAMI & WATCHARIN LOILOME. (2016) Xanthohumol inhibits STAT3 activation pathway leading to growth suppression and apoptosis induction in human cholangiocarcinoma cells. Oncology Reports 35:4, pages 2065-2072.
Crossref
Crossref
Jing Wang, Xiaohui Deng, Yang Yang, Xingsheng Yang, Beihua Kong & Lan Chao. (2016) Expression of GRIM-19 in adenomyosis and its possible role in pathogenesis. Fertility and Sterility 105:4, pages 1093-1101.
Crossref
Crossref
M Buchert, C J Burns & M Ernst. (2015) Targeting JAK kinase in solid tumors: emerging opportunities and challenges. Oncogene 35:8, pages 939-951.
Crossref
Crossref
Hai-Feng Zhang, Ye Chen, Chengsheng Wu, Zhi-Yong Wu, David J. Tweardy, Abdulraheem Alshareef, Lian-Di Liao, Yu-Jie Xue, Jian-Yi Wu, Bo Chen, Xiu-E Xu, Keshav Gopal, Nidhi Gupta, En-Min Li, Li-Yan Xu & Raymond Lai. (2016) The Opposing Function of STAT3 as an Oncoprotein and Tumor Suppressor Is Dictated by the Expression Status of STAT3β in Esophageal Squamous Cell Carcinoma. Clinical Cancer Research 22:3, pages 691-703.
Crossref
Crossref
Peibin Yue, Francisco Lopez-Tapia, David Paladino, Yifei Li, Chih-Hong Chen, Andrew T. Namanja, Tyvette Hilliard, Yuan Chen, Marcus A. Tius & James Turkson. (2016)
Hydroxamic Acid and Benzoic Acid–Based STAT3 Inhibitors Suppress Human Glioma and Breast Cancer Phenotypes
In Vitro
and
In Vivo
. Cancer Research 76:3, pages 652-663.
Crossref
Crossref
Daiki Katoh, Makoto Nishizuka, Shigehiro Osada & Masayoshi Imagawa. (2016) FAD104, a Regulator of Adipogenesis and Osteogenesis, Interacts with the C-Terminal Region of STAT3 and Represses Malignant Transformation of Melanoma Cells. Biological & Pharmaceutical Bulletin Biological and Pharmaceutical Bulletin 39:5, pages 849-855.
Crossref
Crossref
Sally Yu Shi, Wei Zhang, Cynthia T. Luk, Tharini Sivasubramaniyam, Jara J. Brunt, Stephanie A. Schroer, Harsh R. Desai, Alexandra Majerski & Minna Woo. (2015) JAK2 promotes brown adipose tissue function and is required for diet- and cold-induced thermogenesis in mice. Diabetologia 59:1, pages 187-196.
Crossref
Crossref
Maximilian Niit, Victoria Hoskin, Esther Carefoot, Mulu Geletu, Rozanne Arulanandam, Bruce Elliott & Leda Raptis. (2015) Cell-cell and cell-matrix adhesion in survival and metastasis: Stat3 versus Akt. Biomolecular Concepts 6:5-6, pages 383-399.
Crossref
Crossref
Dirk Fahrenkamp, Hildegard Schmitz-Van de Leur, Andrea Küster, Nicolas Chatain & Gerhard Müller-Newen. (2015) Src family kinases interfere with dimerization of STAT5A through a phosphotyrosine-SH2 domain interaction. Cell Communication and Signaling 13:1.
Crossref
Crossref
Megan E. Brown, Misty D. Bear, Thomas J. Rosol, Chris Premanandan, William C. Kisseberth & Cheryl A. London. (2015) Characterization of STAT3 expression, signaling and inhibition in feline oral squamous cell carcinoma. BMC Veterinary Research 11:1.
Crossref
Crossref
Ning Wu, Jia Liu, Xiangzhong Zhao, Zhiyong Yan, Bo Jiang, Lijun Wang, Shousong Cao, Dayong Shi & Xiukun Lin. (2015) Cardamonin induces apoptosis by suppressing STAT3 signaling pathway in glioblastoma stem cells. Tumor Biology 36:12, pages 9667-9676.
Crossref
Crossref
Lv-Cui Zhao, Jing Li, Ke Liao, Nian Luo, Qing-Qiang Shi, Zi-Qiang Feng & Di-Long Chen. (2015) Evodiamine Induces Apoptosis and Inhibits Migration of HCT-116 Human Colorectal Cancer Cells. International Journal of Molecular Sciences 16:11, pages 27411-27421.
Crossref
Crossref
Yanmin Zhang, Zhaoxiao Du, Zirong Zhuang, Yanjun Wang, Fen Wang, Shuai Liu, Han Wang, Hairong Feng, Haoyuan Li, Liyan Wang, Xianghong Zhang & Aijun Hao. (2015) E804 induces growth arrest, differentiation and apoptosis of glioblastoma cells by blocking Stat3 signaling. Journal of Neuro-Oncology 125:2, pages 265-275.
Crossref
Crossref
J Zhou, Z Ning, B Wang, E-J Yun, T Zhang, R-C Pong, L Fazli, M Gleave, J Zeng, J Fan, X Wang, L Li, J-T Hsieh, D He & K Wu. (2015) DAB2IP loss confers the resistance of prostate cancer to androgen deprivation therapy through activating STAT3 and inhibiting apoptosis. Cell Death & Disease 6:10, pages e1955-e1955.
Crossref
Crossref
Gabriella Miklossy, Ui Joung Youn, Peibin Yue, Mingming Zhang, Chih-Hong Chen, Tyvette S. Hilliard, David Paladino, Yifei Li, Justin Choi, Jann N. Sarkaria, Joel K. Kawakami, Supakit Wongwiwatthananukit, Yuan Chen, Dianqing Sun, Leng Chee Chang & James Turkson. (2015) Hirsutinolide Series Inhibit Stat3 Activity, Alter GCN1, MAP1B, Hsp105, G6PD, Vimentin, TrxR1, and Importin α-2 Expression, and Induce Antitumor Effects against Human Glioma. Journal of Medicinal Chemistry 58:19, pages 7734-7748.
Crossref
Crossref
Moumita Chatterjee, Edgar Ben-Josef, Dafydd G. Thomas, Meredith A. Morgan, Mark M. Zalupski, Gazala Khan, Charles Andrew Robinson, Kent A. Griffith, Ching-Shih Chen, Thomas Ludwig, Tanios Bekaii-Saab, Arnab Chakravarti & Terence M. Williams. (2015) Caveolin-1 is Associated with Tumor Progression and Confers a Multi-Modality Resistance Phenotype in Pancreatic Cancer. Scientific Reports 5:1.
Crossref
Crossref
Wei Gao, Jennifer McCormick, Mary Connolly, Emese Balogh, Douglas J Veale & Ursula Fearon. (2015) Hypoxia and STAT3 signalling interactions regulate pro-inflammatory pathways in rheumatoid arthritis. Annals of the Rheumatic Diseases 74:6, pages 1275-1283.
Crossref
Crossref
A Kohlmaier, C Fassnacht, Y Jin, H Reuter, J Begum, D Dutta & B A Edgar. (2014) Src kinase function controls progenitor cell pools during regeneration and tumor onset in the Drosophila intestine. Oncogene 34:18, pages 2371-2384.
Crossref
Crossref
Nanmu Yang, Feng Han, Hong Cui, Jinxi Huang, Tao Wang, Yi Zhou & Jinxue Zhou. (2015) Matrine suppresses proliferation and induces apoptosis in human cholangiocarcinoma cells through suppression of JAK2/STAT3 signaling. Pharmacological Reports 67:2, pages 388-393.
Crossref
Crossref
Goldie Y. L. Lui, Zaklina Kovacevic, Sharleen V. Menezes, Danuta S. Kalinowski, Angelica M. Merlot, Sumit Sahni & Des R. Richardson. (2015) Novel Thiosemicarbazones Regulate the Signal Transducer and Activator of Transcription 3 (STAT3) Pathway: Inhibition of Constitutive and Interleukin 6–Induced Activation by Iron Depletion. Molecular Pharmacology 87:3, pages 543-560.
Crossref
Crossref
Hui Xiao, Hemant Kumar Bid, David Jou, Xiaojuan Wu, Wenying Yu, Chenglong Li, Peter J. Houghton & Jiayuh Lin. (2015) A Novel Small Molecular STAT3 Inhibitor, LY5, Inhibits Cell Viability, Cell Migration, and Angiogenesis in Medulloblastoma Cells. Journal of Biological Chemistry 290:6, pages 3418-3429.
Crossref
Crossref
Ioannis Gkouveris, Nikolaos Nikitakis & John Sauk. (2015) STAT3 Signaling in Cancer. Journal of Cancer Therapy 06:08, pages 709-726.
Crossref
Crossref
Hong Sug Kim, Aiguo Li, Susie Ahn, Hua Song & Wei Zhang. (2014) Inositol Polyphosphate-5-Phosphatase F (INPP5F) inhibits STAT3 activity and suppresses gliomas tumorigenicity. Scientific Reports 4:1.
Crossref
Crossref
André L Mencalha, Stephany Corrêa, Daniela Salles, Bárbara Du Rocher, Marcelo F Santiago & Eliana Abdelhay. (2014) Inhibition of STAT3-interacting protein 1 (STATIP1) promotes STAT3 transcriptional up-regulation and imatinib mesylate resistance in the chronic myeloid leukemia. BMC Cancer 14:1.
Crossref
Crossref
Salih Ibrahem, Saleh Al-Ghamdi, Kanwal Baloch, Belal Muhammad, Wakkas Fadhil, Darryl Jackson, Abdolrahman S. Nateri & Mohammad Ilyas. (2014) STAT3 paradoxically stimulates β-catenin expression but inhibits β-catenin function. International Journal of Experimental Pathology 95:6, pages 392-400.
Crossref
Crossref
Hasaya Dokduang, Anchalee Techasen, Nisana Namwat, Narong Khuntikeo, Chawalit Pairojkul, Yoshinori Murakami, Watcharin Loilome & Puangrat Yongvanit. (2014) STATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progression. Journal of Hepato-Biliary-Pancreatic Sciences 21:10, pages 767-776.
Crossref
Crossref
Uddalak Bharadwaj, Moses Kasembeli, T. Eckols, Mikhail Kolosov, Paul Lang, Kurt Christensen, Dean Edwards & David Tweardy. (2014) Monoclonal Antibodies Specific for STAT3β Reveal Its Contribution to Constitutive STAT3 Phosphorylation in Breast Cancer. Cancers 6:4, pages 2012-2034.
Crossref
Crossref
Xiao-San Li, Meng-Jie Hu, Jie Liu, Qian Liu, Zhi-Xing Huang, Shun-Lin Li, Xiao-Jiang Hao, Xiao-Kun Zhang, Xin-Sheng Yao & Jin-Shan Tang. (2014) Cardiac glycosides from the bark of Antiaris toxicaria. Fitoterapia 97, pages 71-77.
Crossref
Crossref
Hai-Feng Zhang & Raymond Lai. (2014) STAT3 in Cancer—Friend or Foe?. Cancers 6:3, pages 1408-1440.
Crossref
Crossref
KAIJIE WU, ZHONGYUN NING, JIANCHENG ZHOU, BIN WANG, JINHAI FAN, JIANNING ZHU, YANG GAO, XINYANG WANG, JER-TSONG HSIEH & DALIN HE. (2014) 2′-Hydroxyflavanone inhibits prostate tumor growth through inactivation of AKT/STAT3 signaling and induction of cell apoptosis. Oncology Reports 32:1, pages 131-138.
Crossref
Crossref
Helena Porsch, Merima Mehić, Berit Olofsson, Paraskevi Heldin & Carl-Henrik Heldin. (2014) Platelet-derived Growth Factor β-Receptor, Transforming Growth Factor β Type I Receptor, and CD44 Protein Modulate Each Other's Signaling and Stability. Journal of Biological Chemistry 289:28, pages 19747-19757.
Crossref
Crossref
Camilla Pilati, Eric Letouzé, Jean-Charles Nault, Sandrine Imbeaud, Anaïs Boulai, Julien Calderaro, Karine Poussin, Andrea Franconi, Gabrielle Couchy, Guillaume Morcrette, Maxime Mallet, Saïd Taouji, Charles Balabaud, Benoit Terris, Frédéric Canal, Valérie Paradis, Jean-Yves Scoazec, Anne de Muret, Catherine Guettier, Paulette Bioulac-Sage, Eric Chevet, Fabien Calvo & Jessica Zucman-Rossi. (2014) Genomic Profiling of Hepatocellular Adenomas Reveals Recurrent FRK-Activating Mutations and the Mechanisms of Malignant Transformation. Cancer Cell 25:4, pages 428-441.
Crossref
Crossref
Yu-Han Huang, Hung-Yu Yang, Ya-Fen Hsu, Pei-Ting Chiu, George Ou & Ming-Jen Hsu. (2013) Src contributes to IL6-induced vascular endothelial growth factor-C expression in lymphatic endothelial cells. Angiogenesis 17:2, pages 407-418.
Crossref
Crossref
Yangmeng Wang, Hongxiu Ning, Fangli Ren, Yuanjiang Zhang, Yu Rong, Yinyin Wang, Fuqin Su, Chenguang Cai, Zhe Jin, Zhiyong Li, Xinqi Gong, Yonggong Zhai, Dianjun Wang, Baoqing Jia, Ying Qiu, Yasuhiko Tomita, Joseph J.Y. Sung, Jun Yu, David M. Irwin, Xiao Yang, Xinyuan Fu, Y. Eugene Chin & Zhijie Chang. (2014) GdX/UBL4A Specifically Stabilizes the TC45/STAT3 Association and Promotes Dephosphorylation of STAT3 to Repress Tumorigenesis. Molecular Cell 53:5, pages 752-765.
Crossref
Crossref
Ui Joung Youn, Gabriella Miklossy, Xingyun Chai, Supakit Wongwiwatthananukit, Onoomar Toyama, Thanapat Songsak, James Turkson & Leng Chee Chang. (2014) Bioactive sesquiterpene lactones and other compounds isolated from Vernonia cinerea. Fitoterapia 93, pages 194-200.
Crossref
Crossref
Katie E. O’Sullivan, John V. Reynolds, Ciara O’Hanlon, Jacintha N. O’Sullivan & Joanne Lysaght. (2013) Could Signal Transducer and Activator of Transcription 3 be a Therapeutic Target in Obesity-Related Gastrointestinal Malignancy?. Journal of Gastrointestinal Cancer 45:1, pages 1-11.
Crossref
Crossref
Jennifer Kim, Mira Patel, Jacob Ruzevick, Christopher Jackson & Michael Lim. (2014) STAT3 Activation in Glioblastoma: Biochemical and Therapeutic Implications. Cancers 6:1, pages 376-395.
Crossref
Crossref
Tetyana Khomenko, Xiaoming Deng, Amrita Ahluwalia, Andrzej Tarnawski, Khushin N. Patel, Zsuzsanna Sandor & Sandor Szabo. (2014) STAT3 and Importins Are Novel Mediators of Early Molecular and Cellular Responses in Experimental Duodenal Ulceration. Digestive Diseases and Sciences 59:2, pages 297-306.
Crossref
Crossref
Li-Yu D. LiuLi-Yun ChangWen-Hung KuoHsiao-Lin HwaYi-Shing LinMeei-Huey JengDon A. rothKing-Jen ChangFon-Jou Hsieh. (2014) Prognostic features of signal transducer and activator of transcription 3 in an ER(+) breast cancer model system. Cancer Informatics 13, pages CIN.S12493.
Crossref
Crossref
Jaymin J. Kathiriya, Ravi Ramesh Pathak, Eric Clayman, Bin Xue, Vladimir N. Uversky & Vrushank Davé. (2014) Presence and utility of intrinsically disordered regions in kinases. Mol. BioSyst. 10:11, pages 2876-2888.
Crossref
Crossref
Aruljothi Subramaniam, Muthu K. Shanmugam, Ekambaram Perumal, Feng Li, Alamelu Nachiyappan, Alan P. Kumar, Benny K. H. Tan & Gautam Sethi. 2014. Perspectives in Cancer Prevention-Translational Cancer Research. Perspectives in Cancer Prevention-Translational Cancer Research
73
87
.
Jared E. Toettcher, Orion D. Weiner & Wendell A. Lim. (2013) Using Optogenetics to Interrogate the Dynamic Control of Signal Transmission by the Ras/Erk Module. Cell 155:6, pages 1422-1434.
Crossref
Crossref
F Hayakawa, K Sugimoto, Y Harada, N Hashimoto, N Ohi, S Kurahashi & T Naoe. (2013) A novel STAT inhibitor, OPB-31121, has a significant antitumor effect on leukemia with STAT-addictive oncokinases. Blood Cancer Journal 3:11, pages e166-e166.
Crossref
Crossref
Jeong-Kook Kim, Joon-Young Kim, Han-Jong Kim, Keun-Gyu Park, Robert A. Harris, Won-Jea Cho, Jae-Tae Lee & In-Kyu Lee. (2013) Scoparone Exerts Anti-Tumor Activity against DU145 Prostate Cancer Cells via Inhibition of STAT3 Activity. PLoS ONE 8:11, pages e80391.
Crossref
Crossref
Naoki Kaneko, Aya Kita, Kentaro Yamanaka & Masamichi Mori. (2013) Combination of YM155, a survivin suppressant with a STAT3 inhibitor: A new strategy to treat diffuse large B-cell lymphoma. Leukemia Research 37:9, pages 1156-1161.
Crossref
Crossref
R Kerek, A Geoffroy, A Bison, N Martin, N Akchiche, G Pourié, D Helle, J-L Guéant, C Bossenmeyer-Pourié & J-L Daval. (2013) Early methyl donor deficiency may induce persistent brain defects by reducing Stat3 signaling targeted by miR-124. Cell Death & Disease 4:8, pages e755-e755.
Crossref
Crossref
Jinxiang Wu, Fen Liu, Jiping Zhao, Yuping Wei, Jinghu Lv, FangZheng Dong, Wenxiang Bi, Xiaoping Wang, Junfei Wang, Wen Liu, Liang Dong & Hong Tian. (2012) Thymic stromal lymphopoietin promotes asthmatic airway remodelling in human lung fibroblast cells through STAT3 signalling pathway. Cell Biochemistry and Function 31:6, pages 496-503.
Crossref
Crossref
Xing Chen, Yuping Du, Jing Nan, Xinxin Zhang, Xiaodong Qin, Yuxin Wang, Jianwen Hou, Qin Wang & Jinbo Yang. (2013) Brevilin A, a Novel Natural Product, Inhibits Janus Kinase Activity and Blocks STAT3 Signaling in Cancer Cells. PLoS ONE 8:5, pages e63697.
Crossref
Crossref
Yeung Ho, Sai-Wah Tsao, Musheng Zeng & Vivian Wai Yan Lui. (2013) STAT3 as a therapeutic target for Epstein-Barr virus (EBV) – associated nasopharyngeal carcinoma. Cancer Letters 330:2, pages 141-149.
Crossref
Crossref
Bruce Grattan. (2013) Plant Sterols as Anticancer Nutrients: Evidence for Their Role in Breast Cancer. Nutrients 5:2, pages 359-387.
Crossref
Crossref
Mohammad Zahid Kamran, Prachi Patil & Rajiv P. Gude. (2013) Role of STAT3 in Cancer Metastasis and Translational Advances. BioMed Research International 2013, pages 1-15.
Crossref
Crossref
Aruljothi Subramaniam, Muthu K. Shanmugam, Ekambaram Perumal, Feng Li, Alamelu Nachiyappan, Xiaoyun Dai, Shivananju Nanjunda Swamy, Kwang Seok Ahn, Alan Prem Kumar, Benny K.H. Tan, Kam Man Hui & Gautam Sethi. (2013) Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1835:1, pages 46-60.
Crossref
Crossref
Saul J. Priceman, Jiehui Deng, Richard Jove & Hua Yu. 2013. Cancer Immunotherapy. Cancer Immunotherapy
435
449
.
Karolina Swiatek-Machado & Bozena Kaminska. 2013. Glioma Signaling. Glioma Signaling
189
208
.
Jason I Couto, Misty D Bear, Jiayuh Lin, Michael Pennel, Samuel K Kulp, William C Kisseberth & Cheryl A London. (2012) Biologic activity of the novel small molecule STAT3 inhibitor LLL12 against canine osteosarcoma cell lines. BMC Veterinary Research 8:1.
Crossref
Crossref
Mulu Geletu, Rozanne Arulanandam, Samantha Greer, Aaron Trotman-Grant, Evangelia Tomai & Leda Raptis. (2012) Stat3 is a positive regulator of gap junctional intercellular communication in cultured, human lung carcinoma cells. BMC Cancer 12:1.
Crossref
Crossref
Niko P. Bretz, Alexei V. Salnikov, Claudia Perne, Sascha Keller, Xiaoli Wang, Claudia T. Mierke, Mina Fogel, Natalie Erbe-Hofmann, Thomas Schlange, Gerhard Moldenhauer & Peter Altevogt. (2012) CD24 controls Src/STAT3 activity in human tumors. Cellular and Molecular Life Sciences 69:22, pages 3863-3879.
Crossref
Crossref
Bhavya Voleti, David J. HammondJr.Jr., Avinash Thirumalai & Alok Agrawal. (2012) Oct-1 acts as a transcriptional repressor on the C-reactive protein promoter. Molecular Immunology 52:3-4, pages 242-248.
Crossref
Crossref
Jinghua Han, Fei Zhang, Man Yu, Peiqi Zhao, Wei Ji, Haichang Zhang, Bing Wu, Yuqing Wang & Ruifang Niu. (2012) RNA interference-mediated silencing of NANOG reduces cell proliferation and induces G0/G1 cell cycle arrest in breast cancer cells. Cancer Letters 321:1, pages 80-88.
Crossref
Crossref
Christopher Jackson, Jacob Ruzevick, Anubhav G. Amin & Michael Lim. (2012) Potential Role for STAT3 Inhibitors in Glioblastoma. Neurosurgery Clinics of North America 23:3, pages 379-389.
Crossref
Crossref
Xiaolei ZhangPeibin YueBrent D. G. Page, Tianshu LiWei ZhaoAndrew T. Namanja, David PaladinoJihe ZhaoYuan Chen, Patrick T. Gunning & James Turkson. (2012) Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts. Proceedings of the National Academy of Sciences 109:24, pages 9623-9628.
Crossref
Crossref
Markus Werner & Hassan Jumaa. (2012) DOCKing innate to adaptive signaling for persistent antibody production. Nature Immunology 13:6, pages 525-526.
Crossref
Crossref
Haifa H Jabara, Douglas R McDonald, Erin Janssen, Michel J Massaad, Narayanaswamy Ramesh, Arturo Borzutzky, Ingrid Rauter, Halli Benson, Lynda Schneider, Sachin Baxi, Mike Recher, Luigi D Notarangelo, Rima Wakim, Ghassan Dbaibo, Majed Dasouki, Waleed Al-Herz, Isil Barlan, Safa Baris, Necil Kutukculer, Hans D Ochs, Alessandro Plebani, Maria Kanariou, Gerard Lefranc, Ismail Reisli, Katherine A Fitzgerald, Douglas Golenbock, John Manis, Sevgi Keles, Reuben Ceja, Talal A Chatila & Raif S Geha. (2012) DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation. Nature Immunology 13:6, pages 612-620.
Crossref
Crossref
P Yue, X Zhang, D Paladino, B Sengupta, S Ahmad, R W Holloway, S B Ingersoll & J Turkson. (2011) Hyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells. Oncogene 31:18, pages 2309-2322.
Crossref
Crossref
Zhenbing You, Dafu Xu, Jian Ji, Wei Guo, Weiguo Zhu & Jingdong He. (2012) JAK/STAT signal pathway activation promotes progression and survival of human oesophageal squamous cell carcinoma. Clinical and Translational Oncology 14:2, pages 143-149.
Crossref
Crossref
Yi-Ying Chiou, Shu-Ling Fu, Wey-Jinq Lin & Chao-Hsiung Lin. (2012) Proteomics analysis of in vitro protein methylation during Src-induced transformation. ELECTROPHORESIS 33:3, pages 451-461.
Crossref
Crossref
Li-Yu Daisy LiuLi-Yun ChangWen-Hung KuoHsiao-Lin HwaYi-Shing LinShiu-Feng HuangChiung-Nien ChenKing-Jen ChangFon-Jou Hsieh. (2012) Major Functional Transcriptome of an Inferred Center Regulator of an ER(–) Breast Cancer Model System. Cancer Informatics 11, pages CIN.S8633.
Crossref
Crossref
Maciej Kujawski, Gregory Cherryholmes, Saul J. Priceman & Hua Yu. 2012. Targeted Therapeutics in Melanoma. Targeted Therapeutics in Melanoma
89
105
.
Fabio P. S. Santos, Inbal Hazan-Halevy & Zeev Estrov. 2012. Cell Signaling & Molecular Targets in Cancer. Cell Signaling & Molecular Targets in Cancer
299
321
.
Meng Sun, Chengfei Liu, Nagalakshmi Nadiminty, Wei Lou, Yezi Zhu, Joy Yang, Christopher P. Evans, Qinghua Zhou & Allen C. Gao. (2012) Inhibition of Stat3 activation by sanguinarine suppresses prostate cancer cell growth and invasion. The Prostate 72:1, pages 82-89.
Crossref
Crossref
Barbara C Merk, Jennifer L Owens, Maria-Beatriz S Lopes, Corinne M Silva & Isa M Hussaini. (2011) STAT6 expression in glioblastoma promotes invasive growth. BMC Cancer 11:1.
Crossref
Crossref
Leda Raptis, Rozanne Arulanandam, Mulu Geletu & James Turkson. (2011) The R(h)oads to Stat3: Stat3 activation by the Rho GTPases. Experimental Cell Research 317:13, pages 1787-1795.
Crossref
Crossref
Lizhen Wang, Natalie A. Rodrigues, Ying Wu, Bart M. Maslikowski, Nishi Singh, Samantha Lacroix & Pierre-André Bédard. (2011) Pleiotropic Action of AP-1 in v-Src-Transformed Cells. Journal of Virology 85:13, pages 6725-6735.
Crossref
Crossref
Soumya Jaganathan, Peibin Yue, David C. Paladino, Jelena Bogdanovic, Qun Huo & James Turkson. (2011) A Functional Nuclear Epidermal Growth Factor Receptor, Src and Stat3 Heteromeric Complex in Pancreatic Cancer Cells. PLoS ONE 6:5, pages e19605.
Crossref
Crossref
Lanxi Song, Bhupendra Rawal, Jeffrey A. Nemeth & Eric B. Haura. (2011) JAK1 Activates STAT3 Activity in Non-Small–Cell Lung Cancer Cells and IL-6 Neutralizing Antibodies Can Suppress JAK1-STAT3 Signaling. Molecular Cancer Therapeutics 10:3, pages 481-494.
Crossref
Crossref
Vijay M. Shahani, Peibin Yue, Steven Fletcher, Sumaiya Sharmeen, Mahadeo A. Sukhai, Diana P. Luu, Xiaolei Zhang, Hong Sun, Wei Zhao, Aaron D. Schimmer, James Turkson & Patrick T. Gunning. (2011) Design, synthesis, and in vitro characterization of novel hybrid peptidomimetic inhibitors of STAT3 protein. Bioorganic & Medicinal Chemistry 19:5, pages 1823-1838.
Crossref
Crossref
Amandine Chaix, Sophie Lopez, Edwige Voisset, Laurent Gros, Patrice Dubreuil & Paulo De Sepulveda. (2011) Mechanisms of STAT Protein Activation by Oncogenic KIT Mutants in Neoplastic Mast Cells. Journal of Biological Chemistry 286:8, pages 5956-5966.
Crossref
Crossref
Bart M Maślikowski, Benjamin D Néel, Ying Wu, Lizhen Wang, Natalie A Rodrigues, Germain Gillet & Pierre-André Bédard. (2010) Cellular processes of v-Src transformation revealed by gene profiling of primary cells - Implications for human cancer. BMC Cancer 10:1.
Crossref
Crossref
Wei Zhao, Soumya Jaganathan & James Turkson. (2010) A Cell-permeable Stat3 SH2 Domain Mimetic Inhibits Stat3 Activation and Induces Antitumor Cell Effects in Vitro. Journal of Biological Chemistry 285:46, pages 35855-35865.
Crossref
Crossref
Li Li, Shing-hu Cheung, Emma L. Evans & Peter E. Shaw. (2010) Modulation of Gene Expression and Tumor Cell Growth by Redox Modification of STAT3. Cancer Research 70:20, pages 8222-8232.
Crossref
Crossref
Kenneth Leslie, Sizhi P Gao, Marjan Berishaj, Katrina Podsypanina, Hao Ho, Lionel Ivashkiv & Jacqueline Bromberg. (2010) Differential interleukin-6/Stat3 signaling as a function of cellular context mediates Ras-induced transformation. Breast Cancer Research 12:5.
Crossref
Crossref
Ramaswamy Kannappan, Vivek R. Yadav & Bharat B. Aggarwal. (2010) γ-Tocotrienol but Not γ-Tocopherol Blocks STAT3 Cell Signaling Pathway through Induction of Protein-tyrosine Phosphatase SHP-1 and Sensitizes Tumor Cells to Chemotherapeutic Agents. Journal of Biological Chemistry 285:43, pages 33520-33529.
Crossref
Crossref
Chun TuCesar F. Ortega-CavaPaul WinogradMarissa Jo StantonAlagarsamy Lakku ReddiIngrid DodgeRanjana AryaManjari Dimri, Robert J. ClubbMayumi NaramuraKay-Uwe WagnerVimla Band & Hamid Band. (2010) Endosomal-sorting complexes required for transport (ESCRT) pathway-dependent endosomal traffic regulates the localization of active Src at focal adhesions. Proceedings of the National Academy of Sciences 107:37, pages 16107-16112.
Crossref
Crossref
Zu-Yin Yu, Rui Huang, He Xiao, Wen-Feng Sun, Ya-Jun Shan, Bo Wang, Ting-Ting Zhao, Bo Dong, Zhen-Hu Zhao, Xiao-Lan Liu, Sheng-Qi Wang, Ri-Fang Yang, Qing-Liang Luo & Yu-Wen Cong. (2010) Fluacrypyrim, a novel STAT3 activation inhibitor, induces cell cycle arrest and apoptosis in cancer cells harboring constitutively-active STAT3. International Journal of Cancer 127:6, pages 1259-1270.
Crossref
Crossref
Fumihiko Okumura, Yui Matsunaga, Yuta Katayama, Keiichi I. Nakayama & Shigetsugu Hatakeyama. (2010) TRIM8 modulates STAT3 activity through negative regulation of PIAS3. Journal of Cell Science 123:13, pages 2238-2245.
Crossref
Crossref
Soumya Jaganathan, Peibin Yue & James Turkson. (2010) Enhanced Sensitivity of Pancreatic Cancer Cells to Concurrent Inhibition of Aberrant Signal Transducer and Activator of Transcription 3 and Epidermal Growth Factor Receptor or Src. Journal of Pharmacology and Experimental Therapeutics 333:2, pages 373-381.
Crossref
Crossref
Xiaolei Zhang, Peibin Yue, Steven Fletcher, Wei Zhao, Patrick T. Gunning & James Turkson. (2010) A novel small-molecule disrupts Stat3 SH2 domain–phosphotyrosine interactions and Stat3-dependent tumor processes. Biochemical Pharmacology 79:10, pages 1398-1409.
Crossref
Crossref
Li Lin, Brian Hutzen, Mingxin Zuo, Sarah Ball, Stephanie Deangelis, Elizabeth Foust, Bulbul Pandit, Michael A. Ihnat, Satyendra S. Shenoy, Samuel Kulp, Pui-Kai Li, Chenglong Li, James Fuchs & Jiayuh Lin. (2010) Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells. Cancer Research 70:6, pages 2445-2454.
Crossref
Crossref
Bernd Koeberlein, Axel zur Hausen, Nuran Bektas, Hanswalter Zentgraf, Ruth Chin, Nguyen Linh Toan, Reinhard Kandolf, Joseph Torresi & C.- Thomas Bock. (2010) Hepatitis B virus overexpresses suppressor of cytokine signaling-3 (SOCS3) thereby contributing to severity of inflammation in the liver. Virus Research 148:1-2, pages 51-59.
Crossref
Crossref
Displaying 200 of 539 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list